1例因阿托伐他汀而加重的银屑病病例。
A case of psoriasis worsened by atorvastatin.
作者信息
Cozzani Emanuele, Scaparro Manuela, Parodi Aurora
机构信息
Di.S.E.M. Section of Dermatology, University of Genoa, Italy.
出版信息
J Dermatol Case Rep. 2009 Dec 30;3(4):60-1. doi: 10.3315/jdcr.2009.1037.
Abstract
Statins are known to have a number of cutaneous adverse effects including the induction of autoimmune diseases like systemic and subacute lupus erythematosus, dermatomyositis, polymyositis, lichen planus pemphigoides and the drug reaction with eosinophilia and systemic symptoms (DRESS). Statins have been also reported as a triggering factor of psoriasis. We report a case of psoriasis vulgaris that worsened three months after atorvastatin was introduced and improved after its discontinuance.
摘要
已知他汀类药物有多种皮肤不良反应，包括诱发自身免疫性疾病，如系统性和亚急性红斑狼疮、皮肌炎、多发性肌炎、扁平苔藓类天疱疮以及药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）。也有报道称他汀类药物是银屑病的诱发因素。我们报告一例寻常型银屑病病例，在开始服用阿托伐他汀三个月后病情加重，停药后病情改善。
相似文献
1
A case of psoriasis worsened by atorvastatin.
J Dermatol Case Rep. 2009 Dec 30;3(4):60-1. doi: 10.3315/jdcr.2009.1037.
2
Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.
J Eur Acad Dermatol Venereol. 2007 Jan;21(1):17-24. doi: 10.1111/j.1468-3083.2006.01838.x.
3
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].
Ann Dermatol Venereol. 2009 Jan;136(1):50-3. doi: 10.1016/j.annder.2008.07.063. Epub 2008 Nov 28.
4
Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.
Br J Dermatol. 2019 Sep;181(3):580-583. doi: 10.1111/bjd.17245. Epub 2018 Dec 10.
5
[Simvastatin-induced lichen planus pemphigoides].
Ann Dermatol Venereol. 2003 Feb;130(2 Pt 1):187-90.
6
Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events.
Cureus. 2020 Mar 1;12(3):e7155. doi: 10.7759/cureus.7155.
7
Narrowband UVB-induced lichen planus pemphigoide.
Dermatol Reports. 2011 Oct 25;3(3):e43. doi: 10.4081/dr.2011.e43. eCollection 2011 Oct 5.
8
Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies.
Periodontol 2000. 2019 Jun;80(1):105-125. doi: 10.1111/prd.12260.
9
[Concurrence of lichen planus pemphigoides and ulcerative colitis (author's transl)].
Z Hautkr. 1981 Mar 15;56(6):378-84.
10
Lichen planus of the eyelids.
Dermatology. 1995;191(4):350-1. doi: 10.1159/000246599.
引用本文的文献
1
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults.
Curr Atheroscler Rep. 2025 May 1;27(1):54. doi: 10.1007/s11883-025-01298-8.
2
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.
Int J Mol Sci. 2025 Jan 10;26(2):535. doi: 10.3390/ijms26020535.
3
Atorvastatin-Associated Eosinophilic Spongiosis: A Case Report and a Relevant Literature Review of Dermatological Manifestations.
Cureus. 2024 May 25;16(5):e61071. doi: 10.7759/cureus.61071. eCollection 2024 May.
4
Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.
Skin Res Technol. 2024 Apr;30(4):e13689. doi: 10.1111/srt.13689.
5
The Causal Association Between Medication Intake and Increased Risk of Psoriasis.
Dermatol Pract Concept. 2024 Jan 1;14(1):e2024041. doi: 10.5826/dpc.1401a41.
6
Genetically proxied PCSK9 inhibition is associated with reduced psoriatic arthritis risk.
Inflamm Res. 2024 Mar;73(3):475-484. doi: 10.1007/s00011-024-01850-3. Epub 2024 Feb 11.
7
Crosstalk between cholesterol metabolism and psoriatic inflammation.
Front Immunol. 2023 May 10;14:1124786. doi: 10.3389/fimmu.2023.1124786. eCollection 2023.
8
Effects of Hypolipidemic Drugs on Psoriasis.
Metabolites. 2023 Mar 29;13(4):493. doi: 10.3390/metabo13040493.
9
The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials.
Arch Med Sci. 2019 Dec 6;16(1):1-7. doi: 10.5114/aoms.2019.90343. eCollection 2020.
10
A Case of Psoriasis Vulgaris Aggravated with Atorvastatin, Aided by Concomitant Cyclosporine.
Indian J Dermatol. 2017 Sep-Oct;62(5):537-538. doi: 10.4103/ijd.IJD_749_16.
本文引用的文献
1
[Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)].
Ann Dermatol Venereol. 2009 Jan;136(1):50-3. doi: 10.1016/j.annder.2008.07.063. Epub 2008 Nov 28.
2
Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.
J Dermatol. 2008 Nov;35(11):732-6. doi: 10.1111/j.1346-8138.2008.00558.x.
3
A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct.
Chem Res Toxicol. 2009 Jan;22(1):173-78. doi: 10.1021/tx800294z.
4
[Cutaneous adverse effects of statins].
Ann Dermatol Venereol. 2008 Mar;135(3):253-4. doi: 10.1016/j.annder.2008.01.003. Epub 2008 Mar 4.
5
Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review.
J Eur Acad Dermatol Venereol. 2007 Jan;21(1):17-24. doi: 10.1111/j.1468-3083.2006.01838.x.
6
Drugs in exacerbation of psoriasis.
J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1007-22. doi: 10.1016/s0190-9622(86)70265-x.
Zotero 插件